Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tapan M Kadia

Showing results (1-10 of 277) with videos related to

Pageof 28
Sort By:
Blood|March 19, 2016
Release the hounds: virotherapy with immunotherapyTapan M Kadia
Clinical Advances in Hematology & Oncology : H&O|June 9, 2021
FLT3 inhibitors in acute myeloid leukemia: increasing optionsTapan M Kadia
Clinical Advances in Hematology & Oncology : H&O|July 6, 2016
Personalized treatment for patients with myelofibrosisTapan M Kadia
Clinical Advances in Hematology & Oncology : H&O|January 21, 2022
Changing paradigms in the treatment of acute myeloid leukemia in older patientsAlexandre Bazinet, Tapan M Kadia
The Lancet. Haematology|January 15, 2016
Alemtuzumab in T-cell large granular lymphocyte leukaemiaTapan M Kadia, Farhad Ravandi
Expert Review of Hematology|November 22, 2016
Nelarabine in the treatment of pediatric and adult patients with T-cell acute lymphoblastic leukemia and lymphomaTapan M Kadia, Varsha Gandhi
European Journal of Haematology|November 1, 2018
Molecular pathogenesis of acquired aplastic anemiaPrajwal C Boddu, Tapan M Kadia
Cancer Journal (Sudbury, Mass.)|January 24, 2022
Evolution of Therapy for Older Patients With Acute Myeloid Leukemia: How Should We Use Currently Available Agents?Tapan M Kadia, Andrew H Wei
Expert Review of Hematology|November 19, 2010
Role of epigenetic therapy in myelodysplastic syndromeTapan M Kadia, Guillermo Garcia-Manero
Frontiers in Oncology|February 19, 2021
Maintenance Therapy in AMLPatrick K Reville, Tapan M Kadia
Pageof 28

Showing results (1-10 of 277) with videos related to

Sort By:
Pageof 28
Blood|March 19, 2016
Release the hounds: virotherapy with immunotherapyTapan M Kadia
Clinical Advances in Hematology & Oncology : H&O|June 9, 2021
FLT3 inhibitors in acute myeloid leukemia: increasing optionsTapan M Kadia
Clinical Advances in Hematology & Oncology : H&O|July 6, 2016
Personalized treatment for patients with myelofibrosisTapan M Kadia
Clinical Advances in Hematology & Oncology : H&O|January 21, 2022
Changing paradigms in the treatment of acute myeloid leukemia in older patientsAlexandre Bazinet, Tapan M Kadia
The Lancet. Haematology|January 15, 2016
Alemtuzumab in T-cell large granular lymphocyte leukaemiaTapan M Kadia, Farhad Ravandi
Expert Review of Hematology|November 22, 2016
Nelarabine in the treatment of pediatric and adult patients with T-cell acute lymphoblastic leukemia and lymphomaTapan M Kadia, Varsha Gandhi
European Journal of Haematology|November 1, 2018
Molecular pathogenesis of acquired aplastic anemiaPrajwal C Boddu, Tapan M Kadia
Cancer Journal (Sudbury, Mass.)|January 24, 2022
Evolution of Therapy for Older Patients With Acute Myeloid Leukemia: How Should We Use Currently Available Agents?Tapan M Kadia, Andrew H Wei
Expert Review of Hematology|November 19, 2010
Role of epigenetic therapy in myelodysplastic syndromeTapan M Kadia, Guillermo Garcia-Manero
Frontiers in Oncology|February 19, 2021
Maintenance Therapy in AMLPatrick K Reville, Tapan M Kadia
Pageof 28